Skip to main content

Table 2 Comparison between the studied groups regarding the baseline data

From: Stenting deferral in primary percutaneous coronary intervention: exploring benefits and suitable interval in heavy thrombus burden

Clinical data Group A (N = 50) Group B (N = 50) Group C (N = 50) p value
Age (years) 50.8 ± 9.8 49.8 ± 10.3 54.0 ± 11.0 0.117
Risk factors
 Male gender 37 (74%) 38 (76%) 41 (82%) 0.610
 DM 16 (32%) 14 (28%) 17 (34%) 0.805
 HTN 27 (54%) 22 (44%) 25 (50%) 0.602
 Smoking 28 (56%) 27 (54%) 26 (52%) 0.923
 Dyslipidemia 15 (30%) 11 (22%) 15 (30%) 0.584
 IHD 3 (6%) 6 (12%) 5 (10%) 0.576
Diagnosis
 Anterior STEMI 19 (38%) 29 (58%) 32 (64%) 0.111
 Inferior STEMI 29 (58%) 20 (40%) 17 (34%)
 Lateral STEMI 2 (4%) 1 (2%) 1 (2%)
Heart rate (beat/min) 95 (90–110) 95 (90–110) 98 (90–110) 0.699
SBP (mmHg) 117.5 (100–130) 120 (100–130) 120 (100–130) 0.904
DBP (mmHg) 70 (60–80) 75 (60–80) 75 (60–80) 0.840
Killip class
 Class 1 29 (58%) 26 (52%) 26 (52%) 0.342
 Class 2 19 (38%) 20 (40%) 19 (38%)
 Class 3 2 (4%) 4 (8%) 5 (10%)
Baseline EF (%) 40 (38–46) 40 (38–47) 40 (38–47) 0.831
Serum Creatinine (mg/dL) 1.0 (0.9–1.1) 1.0 (0.9–1.2) 1.0 (0.9–1.2) 0.779